NCT01053403
- Conditions
- Behavior, Chemically-Induced Disorders, MDMA Discontinuation Syndrome, +3 more
- Locations
-
- CPMC Addiction & Pharmacology Research Laboratory (APRL) San Francisco, California, United States
Clinical trial condition
MDMA Discontinuation Syndrome
Explore clinical trials studying MDMA Discontinuation Syndrome. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies